| Geld/Brief | 1,36 € / 1,40 € |
| Spread | +2,94% |
| Schluss Vortag | 1,38 € |
| Gehandelte Stücke | 0 |
| Tagesvolumen Vortag | - |
| Tagestief 1,36 € Tageshoch 1,36 € | |
| 52W-Tief 1,25 € 52W-Hoch 5,60 € | |
| Jahrestief 1,25 € Jahreshoch 4,46 € | |
| Umsatz in Mio. | - |
| Operatives Ergebnis (EBIT) in Mio. | -13,48 $ |
| Jahresüberschuss in Mio. | -6,61 $ |
| Umsatz je Aktie | - |
| Gewinn je Aktie | -0,02 $ |
| Gewinnrendite | - |
| Umsatzrendite | - |
| Return on Investment | -17,76% |
| Marktkapitalisierung in Mio. | 195,45 $ |
| KGV (Kurs/Gewinn) | -199,00 |
| KBV (Kurs/Buchwert) | 33,17 |
| KUV (Kurs/Umsatz) | - |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | +88,65% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| AMEX | 1,595 $ | -0,93% | 1,61 $ | 15.09.26 | |
| Düsseldorf | 1,35 € | -0,74% | 1,36 € | 09:30 | |
| Frankfurt | 1,36 € | -1,45% | 1,38 € | 08:02 | |
| Gettex | 1,38 € | 0 % | 1,38 € | 10:14 | |
| L&S RT | 1,375 € | -1,08% | 1,39 € | 10:39 | |
| Nasdaq | 1,595 $ | -0,93% | 1,61 $ | 15.09.26 | |
| NYSE | 1,595 $ | -1,24% | 1,615 $ | 15.09.26 | |
| Quotrix | 1,38 € | -2,13% | 1,41 € | 07:27 | |
| Stuttgart | 1,35 € | -1,46% | 1,37 € | 10:20 | |
| Tradegate | 1,39 € | -0,71% | 1,40 € | 11.09.26 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 15.09.26 | 1,38 | 0 |
| 14.09.26 | 1,35 | 0 |
| 11.09.26 | 1,43 | 0 |
| 10.09.26 | 1,44 | 0 |
| 09.09.26 | 1,51 | 0 |
| 08.09.26 | 1,52 | 0 |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 1,52 € | -9,21% |
| 1 Monat | 1,62 € | -14,81% |
| 6 Monate | 2,50 € | -44,80% |
| 1 Jahr | 3,42 € | -59,65% |
| 5 Jahre | 58,00 € | -97,62% |
| Marktkapitalisierung | 195,45 Mio. $ |
| Streubesitz | 100,00% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | ADR |
| +5,22% | HHG PLC |
| +5,17% | Hillhouse Capital Advisors, Ltd. |
| +3,32% | Morgan Stanley - Brokerage Accounts |
| +2,59% | Siren, L.L.C. |
| +1,99% | Point72 Asset Management, L.P. |
| +1,96% | AIHC Capital Management Limited |
| +0,98% | Candriam Luxembourg S.C.A. |
| +0,98% | Belfius Equities Cure C Cap |
| +0,89% | E Fund Global Medi Inds Allc QDII CNY A |
| +0,86% | Adage Capital Partners Gp LLC |
| +0,61% | Woodline Partners LP |
| +0,53% | BlackRock Inc |
| +0,51% | E Fund Management Co., Ltd. |
| +0,46% | iShares Biotechnology ETF |
| +0,43% | Exome Asset Management LLC |
| +0,32% | State Street Corp |
| +0,27% | Fiera Capital Corporation |
| +0,27% | OAKS Emerg and Frntr Opp A EUR Acc Ser 4 |
| +0,26% | State Street® SPDR® Portfolio EM ETF |
| +0,26% | Barclays PLC |
| +0,24% | Renaissance Technologies Corp |
| +0,15% | TAIKANG ASSET MANAGEMENT (HONG KONG) CO LTD |
| +0,14% | Citadel Advisors Llc |
| +0,13% | Dimensional Fund Advisors, Inc. |
| +0,12% | XTX Topco Ltd |
| +0,11% | Taikang Kaitai China New Opp I HKD Acc |
| +0,1% | ALPS Medical Breakthroughs ETF |
| +0,1% | ALPS Advisors Inc |
| +0,1% | The Goldman Sachs Group Inc |
| +0,09% | HRT FINANCIAL LLC |
| +0,07% | iShares Nasdaq US Biotech ETF USD Acc |
| +0,07% | AXQ CAPITAL LP |
| +0,07% | Dymon Asia Capital (Singapore) Pte. Ltd |
| +0,06% | Fidelity Nasdaq Composite Index |
| +0,04% | State Street® SPDR® S&P® EM Sm Cp ETF |
| +0,03% | DFA Emerging Markets Small Cap I |
| +0,02% | Invesco NASDAQ Future Gen 200 ETF |
| +0,02% | DFA World ex US Core Equity Instl |
| +0,02% | DFA Emerging Markets Core Equity 2 I |
| +0,02% | DFA Emerging Markets Social Core Port |
| +0,01% | Dimensional World Allc 60/40 GBP Acc |
| +0,01% | State Street® SPDR® S&P® China ETF |
| +0,01% | Invesco Nasdaq Biotechnology ETF |
| +0,01% | Dimensional World Equity GBP Acc |
| +0,01% | DFA Em Mkts Sustnby Cor 1 Instl |
| +0,01% | China Universal NASDAQ Bio-Tch ETF(QDII) |
| - % | ProShares Ultra Nasdaq Biotechnology |
| - % | ProFunds UltraChina Inv |
| - % | GF NASDAQ Bio-Tech Idx QDII USD A |
| +100,00% | Streubesitz |
